PODD Insulet Corp

Price (delayed)

$187.27

Market cap

$13.12B

P/E Ratio

55.9

Dividend/share

N/A

EPS

$3.35

Enterprise value

$13.77B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2714.8 and 58% lower than its last 4 quarters average of 134.4
The equity has soared by 57% YoY and by 8% QoQ

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
70.04M
Market cap
$13.12B
Enterprise value
$13.77B
Valuations
Price to book (P/B)
16.56
Price to sales (P/S)
7.36
EV/EBIT
50.04
EV/EBITDA
39.39
EV/Sales
7.73
Earnings
Revenue
$1.78B
EBIT
$275.1M
EBITDA
$349.5M
Free cash flow
$111.6M
Per share
EPS
$3.35
Free cash flow per share
$1.6
Book value per share
$11.31
Revenue per share
$25.45
TBVPS
$35.36
Balance sheet
Total assets
$2.62B
Total liabilities
$1.83B
Debt
$1.4B
Equity
$790.7M
Working capital
$1.19B
Liquidity
Debt to equity
1.77
Current ratio
3.74
Quick ratio
2.48
Net debt/EBITDA
1.86
Margins
EBITDA margin
19.6%
Gross margin
68.9%
Net margin
13.1%
Operating margin
14%
Efficiency
Return on assets
9.3%
Return on equity
34.9%
Return on invested capital
10.4%
Return on capital employed
12.6%
Return on sales
15.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
1.02%
1 week
12.88%
1 month
12.64%
1 year
-40.2%
YTD
-13.69%
QTD
9.26%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.78B
Gross profit
$1.23B
Operating income
$249.2M
Net income
$234M
Gross margin
68.9%
Net margin
13.1%
PODD's gross profit is up by 47% YoY and by 6% from the previous quarter
PODD's revenue is up by 30% year-on-year and by 4.9% since the previous quarter
PODD's net income is up by 13% since the previous quarter
Insulet's gross margin has increased by 13% YoY

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
P/E
55.9
P/B
16.56
P/S
7.36
EV/EBIT
50.04
EV/EBITDA
39.39
EV/Sales
7.73
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2714.8 and 58% lower than its last 4 quarters average of 134.4
The EPS has grown by 13% from the previous quarter
PODD's price to book (P/B) is 64% less than its 5-year quarterly average of 46.0 and 27% less than its last 4 quarters average of 22.6
The equity has soared by 57% YoY and by 8% QoQ
PODD's price to sales (P/S) is 49% lower than its 5-year quarterly average of 14.3 and 19% lower than its last 4 quarters average of 9.1
PODD's revenue is up by 30% year-on-year and by 4.9% since the previous quarter

Efficiency

How efficient is Insulet business performance
The return on assets has increased by 9% since the previous quarter
Insulet's return on invested capital has increased by 7% QoQ
The ROS has grown by 4.1% from the previous quarter

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 43% higher than the total liabilities
The total assets rose by 15% YoY
Insulet's quick ratio has increased by 13% YoY and by 5% from the previous quarter
The company's debt is 77% higher than its equity
The equity has soared by 57% YoY and by 8% QoQ
The debt to equity has decreased by 36% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.